NUTRA GOODNESS Trademark
Trademark Overview
On Monday, April 29, 2024, a trademark application was filed for NUTRA GOODNESS with the United States Patent and Trademark Office. The USPTO has given the NUTRA GOODNESS trademark a serial number of 98524088. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 2, 2024. This trademark is owned by Aastar Pte Ltd. The NUTRA GOODNESS trademark is filed in the Pharmaceutical Products category with the following description:
Cardiovascular pharmaceutical preparations; Dietary and nutritional supplements; Dietary food supplements; Dietary supplements in the form of liquid; Dietetic beverages adapted for medical purposes; Food for infants; Herbal extracts, other than essential oils, for medical purposes; Herbal supplements; Liquid formula milk for infants; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Mineral food supplements; Mineral supplements; Nutritional supplements; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidn...
General Information
| Serial Number | 98524088 |
| Word Mark | NUTRA GOODNESS |
| Filing Date | Monday, April 29, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, December 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 24, 2024 |
Trademark Statements
| Description of Mark | The mark consists of "NUTRA" appearing above the term "GOODNESS". The word "NUTRA" is depicted in green, while the term "GOODNESS" is depicted in black. To the left of this wording is a graphic of a heart. The left segment of the heart is depicted in light green, whereas the right segment is depicted in dark green, with the latter also evoking the image of a leaf. The color white represents background and transparent areas only and is not part of the mark. |
| Goods and Services | Cardiovascular pharmaceutical preparations; Dietary and nutritional supplements; Dietary food supplements; Dietary supplements in the form of liquid; Dietetic beverages adapted for medical purposes; Food for infants; Herbal extracts, other than essential oils, for medical purposes; Herbal supplements; Liquid formula milk for infants; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Mineral food supplements; Mineral supplements; Nutritional supplements; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Protein dietary supplements; Vitamin preparations; Vitamin supplements |
| Indication of Colors claimed | The color(s) green, black, light green, and dark green is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Aastar Pte Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Singapore 369585
SG |
Trademark Events
| Event Date | Event Description |
| Monday, April 29, 2024 | NEW APPLICATION ENTERED |
| Monday, October 21, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, October 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 13, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, November 20, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, November 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
